COVID-19 Vaccine Acceptance among University Students and Lecturers in Different Provinces of Indonesia: A Cross-Sectional Study

Author:

Khatiwada Madan1ORCID,Nugraha Ryan Rachmad2,Harapan Harapan34ORCID,Dochez Carine1ORCID,Mutyara Kuswandewi5,Rahayuwati Laili6ORCID,Syukri Maimun7ORCID,Wardoyo Eustachius Hagni8,Suryani Dewi8,Que Bertha J.9,Kartasasmita Cissy10

Affiliation:

1. Network for Education and Support in Immunisation (NESI), University of Antwerp, 2610 Antwerp, Belgium

2. USAID Health Financing Activity/ThinkWell, Jakarta 10110, Indonesia

3. Medical Research Unit, School of Medicine, Universitas Syiah Kuala, Banda Aceh 23111, Indonesia

4. Department of Microbiology, School of Medicine, Universitas Syiah Kuala, Banda Aceh 23111, Indonesia

5. Department of Public Health, Faculty of Medicine, Universitas Padjadjaran, Bandung 45363, Indonesia

6. Faculty of Nursing, Universitas Padjadjaran, Bandung 45363, Indonesia

7. Department of Internal Medicine, School of Medicine, Universitas Syiah Kuala, Banda Aceh 23111, Indonesia

8. Department of Microbiology, School of Medicine, Universitas Mataram, Mataram 83125, Indonesia

9. Faculty of Medicine, Universitas Pattimura, Ambon 97233, Indonesia

10. Department of Pediatric, Rumah Sakit Umum Pusat Hasan Sadikin, Bandung 40161, Indonesia

Abstract

The coronavirus disease 2019 (COVID-19) pandemic imposed a pressing global threat. Vaccines against COVID-19 are a key tool to control the ongoing pandemic. The success of COVID-19 vaccination programs will largely depend on public willingness to receive the vaccine. This study aimed to evaluate the acceptability of COVID-19 vaccines among university students and lecturers in four different provinces of Indonesia. An anonymous, cross-sectional study was conducted online among university students and lecturers in Indonesia between 23 December 2020 and 15 February 2021. Of 3433 respondents, 50.3% stated that they would accept COVID-19 vaccination, while 10.7% expressed unwillingness and 39% were not sure about receiving the vaccine. Concern regarding the side effects after COVID-19 vaccination was the main reason among the participants for not willing to receive the vaccine. Being male, associated with the health sector, having a higher monthly expenditure and having health insurance could increase the acceptability of the COVID-19 vaccine. Low trust in the government and low confidence towards vaccine safety and efficacy could hinder participants’ decision to be vaccinated. Simple, clear and fact-based information from trusted sources on a regular basis will be important for building confidence towards the COVID-19 vaccination program in Indonesia.

Publisher

MDPI AG

Subject

Pharmacology (medical),Infectious Diseases,Drug Discovery,Pharmacology,Immunology

Reference43 articles.

1. The determinants of COVID-19 morbidity and mortality across countries;Chang;Sci. Rep.,2022

2. Johns Hopkins Coronavirus Resource Center (2023, February 15). New COVID-19 Cases Worldwide. Available online: https://coronavirus.jhu.edu/data/new-cases.

3. Machado, B.A.S., Hodel, K.V.S., Fonseca, L.M.D.S., Pires, V.C., Mascarenhas, L.A.B., da Silva Andrade, L.P.C., Moret, M.A., and Badaró, R. (2022). The Importance of Vaccination in the Context of the COVID-19 Pandemic: A Brief Update Regarding the Use of Vaccines. Vaccines, 10.

4. World Health Organization (WHO) (2023, February 15). Draft Landscape and Tracker of COVID-19 Candidate Vaccines. Available online: https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines.

5. Bloom, B.R., and Lambert, P.-H. (2016). The Vaccine Book, Academic Press. [2nd ed.].

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3